DrMichael Loebinger

Professor Loebinger is Professor of Practice (Respiratory Medicine) at the National Heart and Lung Institute and Consultant Respiratory Physician at the Royal Brompton Hospital where he leads the Respiratory Directorate and is Deputy Medical Director.

He undertook his preclinical studies at Cambridge University gaining a First Class Honours in Medical Sciences followed by study at Oxford University for his clinical studies. He was then awarded a Medical Research Council Clinical Research Training Fellowship in 2006 for studies into the use of adult stem cells in lung disease. This resulted in research published in his PhD, which he was awarded by University College London.

His current research aims focus around chronic lung infections, in particular bronchiectasis and aspergillus, Pseudomonas and non-tuberculosis mycobacterial infections. He co-chaired the National bronchiectasis guidelines and co-wrote the European bronchiectasis guidelines and National non-tuberculous mycobacteria guidelines. He chaired the British Thoracic Society Specialist Advisory Group for respiratory infections (2013-2016) the European Respiratory Society respiratory infection group. He has helped set up national and European research networks and is the recipient of several prestigious research grants.  He has published over 200 articles. He also collaborates with Industry and is global, national and site principal investigator of multicentre international clinical trials. He has won investigator of the year awards from the Royal Society of Medicine, the European Respiratory Society, the British Thoracic Society and the British Association of Lung Research. In addition, he has won prestigious awards from the American Thoracic Society, the Medical Research Society and the British Lung Foundation and was awarded the European Respiratory Society research award for innovation in non-tuberculous Mycobacteria in 2018.

His clinical interests include respiratory infection, particularly host defence abnormalities, bronchiectasis, primary ciliary dyskinesia, primary immunodeficiency, non-tuberculosis mycobacterial infections and cystic fibrosis.